Amterdam Institute for Global health & Development aighd
1
Ana Cecília Gomes Rosa Luiz, Bruna Silveira Caixeta, Milena Ferreira Cruvinel et al.
1
Anaya-Covarrubias, J.Y.
1
and L.Lockerd Maragakis
1
and C. Hoffmann
1
and C. Wonodi
1
and K. Geffert
1
Argote P., Barhan E., Zukerman Daly S. et al.
1
Armocida, B.
1
Arrieta, A.
1
ARUP Laboratories
1
Asean Briefing
1
Australian Government Department of Health
1
ÄZQ
1
B. Mason Meier
1
B.S. Kamps
1
BC Centre for Disease Control
1
Beauftragte der Bundesregierung für Migration, Flüchtlinge und Integration
1
Berger, S.
1
Bhopal,S., and M. Nielsen
1
Bigoni, A.
1
BioNTech
1
BMC
1
BMC Health Services
1
Bouley, T. A.
1
Bracho C., Martinez C. et al.
1
Brazilian Journal of Health Review
1
Breathrough Action - For social and behavior change
1
British Medical Association BMA
1
British Medical Journal
1
British Society for Immunology
1
Buliva E., Elnossery S., Okwarah P. et al.
1
Bundesministerium für Migration und Flüchtlinge BAMF
1
C.
1
C. Clift
1
C. Ferreira-Borges
1
C. Victora and M. Chowdury.
1
Camp, R. and C. Hoffmann
1
Care and ONU Femmes
1
Care, ONUu Femmes et al.
1
Carolina L.A. Barbieri, C. Carvalho de Souza Amorim Matos
1
Carrillo-Larco
1
Castillo C., Villalobos Dintrans P. et al
1
Castro, A.
1
Catholic Agency for Overseas Development CAFOD
1
CDA Collaborative Learning Projects
1
Center for Operational Analysis and Research COAR
1
Center for Public Interest Communications, University of Florida
1
Centers for Disease Control and Prevention
1
Cerda A. A., Garcia L. Y.
1
Chairmen of the Committee on Doctrine and the Committee on Pro-Life Activities
1
Children for Health
1
Chimimba, F.
1
Clinical Drug Information, Inc. and its affiliates and
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
Coision Nacional de Seguridad en Vacunas
1
Collective Service RCCE
1
Compass
1
Conlon C., T. McDonnell, M. Barrett, et al.
1
Conseil International des Infirmières
1
Conseil international des Infirmières (CII)
1
Corinne Grainger
1
Corona Tracker
1
Corvalan, C.
1
Couto,M.T.
1
COVID-19 Mental Disorders Collaborators
1
Cristina Aldaz, Francisco Perez
1
D. B. Evans
1
das Neves Martins Pires P.H. , Macaringue C. , Abdirazak A. et al.
1
Department of Health, Republic of South Africa
1
Desogus, A.
1
Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ)
1
Dheda, K.
1
DHS Program Demographic and Health Surveys
1
Dirección de Control de Enfermedades Inmunoprevenibles
1
Dorcas Aid International
1
Doubova SV, Leslie HH, Kruk ME, et al.
1
Dr. J. Breda
1
Dr. P. Amoth
1
Dr. S. K. Kibias
1
Dressler D. D., MD, MSc Director OF
1
Drug Safety
1
Dzabala, N. et al.
1
E. Levy Yeyati
1
E. Ross
1
E. Villalobos Prats, A. Sena et al.
1
E. Webb, M. Mckee et al.
1
Eba, B.
1
Education Santé
1
Elsevier Ltd
1
Emanuel, E.J., et al.
1
Engelman, D. et al.
1
EQUINET
1
et al
1
Ethiopian Food and Drug Authority
1
Ethiopian Food, Medicine and Healthcare Administration and Control Authority
1
EUAA European Union
1
EuroHealth Observer
1
European & Developing Countries Clinical Trials Partnership EDCTTP
1
European AIDS Clinical Society (EACS)
1
European Asylum Support Office
1
European Centers for Disease Control and Prevention ECDC
1
European Centre for disease prevention and Control
1
European Centre for Disease Prevention and Control ECDC
1
European Centre for Disease Prevention and Control (ECDC)
1
European Centre for Disease Prevention and Control ECDC, IOM
1
European Commission's Directorate-General for European Civil Protection and Humanitarian Aid Operations ECHO
1
European Observatory on Health Systems and Policies Eurostation
1
European specialist nurse organisation (ESN)
1
F. Bozzani et al.
1
F. Filippini
1
F. O. Fasina, Fasanmi O.G., Makonnen Y. J., et al.
1
F. Zerbinato Bispo Velasco, de Oliveira Pedroza, G.G. et al.
1
Federal Ministry of Health, Uganda
1
Florida International University
1
Food and Agriculture Organization of the United Nations (FAO)
1
Frase N. S.
1
GAVI Alliance
1
Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO
1
Gavi, the Vaccine Alliance
1
GBD 2019 Human Resources for Health Collaborators
1
GEF
1
German Agency for Quality in Medicine (ÄZQ)
1
Gideon
1
Global Alliance for Vaccines and Immunisation (Gavi)
1
Global Coalition for Circulatory Health
1
Global Financing Facility (GFF)
1
Global Fund
1
Global Institute for Asthma
1
Global Polio Eradication Initiative (GPEI
1
GMDAC, University of Potsdam
1
GOARN
1
Gomes Machado, F.C. et al.
1
Goodman, T.
1
Government of Burundi World Health Organization
1
Government of Malawi
1
Government of the Democratic Republic of the Congo
1
Government of the Republic of Moldova United Nations in Moldova
1
Government of the Republic of Namibia
1
Government of Uganda
1
Greinacher, A., et al.
1
Guzman-Vilca, W. C.
1
H. Adler, Gould, S.
1
Haarmann, E.
1
Haider, N.
1
Haldane, V., De Foo, C., Abdalla, S.M. et al.
1
Harding-Zentrum für Risikokompetenz
1
Hategeka C, Carter SE, Chenge FM, et al.
1
Health Care without Harm
1
Health Cluster, Nutrition Cluster, OCHA
1
Health Cluster, WHO
1
Health Sector Syria
1
Healthcare Triage
1
Heinrich-Böll Stiftung, European Union EU
1
Heliyon
1
Hine, P.
1
Hoffmann, C.
1
Holt, E.
1
Holy See Press Office
1
Honein MA, Christie A, Rose DA, et al.
1
Hopkins, D.
1
Hussein Ahmed
1
ICG
1
IFRC - International Federation of Red Cross
1
IHME Institut for Health Metrics and Evaluation
1
ILO
1
iMMAP
1
Immunization Action Coalition
1
Imperial College COVID-19 Response Team
1
Infection Prevention and Control UHL, WHO Headquarters
1
Institut de Médecine Tropicale, Université de Bordeau
1
Institute for research in international assistance
1
Inter-agency Task Force on Financing for Development
1
International Commission of Jurists
1
International Crisis Group
1
International Federation of Red Cross and Red Crescent Societies IFR
1
International Institute for Environment and Developmend (IIED)
1
International Organization for Migration (IOM)
1
International Rescue Committee
1
International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health
1
IOM Displacement Tracking Matrix - South Sudan
1
IQ-COVID Bremen
1
J. Bueno de Mesquita
1
J. Ferdosy
1
J. Kates, A. Wexler, et al.
1
J. Tjaden
1
Janković, M.
1
Jara A., Undurraga E. A. et al
1
John Hopkins Bloomberg School
1
John Hopkins University
1
Jurkovič, I.
1
Jusot, V.
1
Kalla, I.S.
1
Kelen, G.D.
1
KFF
1
Kim, A.
1
Knoll, M.D.
1
Knowledge Translation Unit
1
Kohler, S.
1
Kompetenznetz Public Health zu COVID-19
1
Kuehn, B.M.
1
Kulkarni, S.
1
Kurowski, C.
1
L. Aparecida de Souza Teles and E.G. da Silva Andrade
1
la DiCEI del Ministerio de Salud de la Nación en conjunto con la Comisión Nacional de Seguridad en Vacunas (CoNaSeVa)
1
Lalloo, U.G.
1
Lancet Oncology Commission
1
Leon-Velarde, F.
1
Lewis, C. Jr., Akinyi, M., DeWitte, S. et al.
1
Limaya, R.J.
1
Logothetis, E.
1
Logunov, D.Y, et al.
1
Louka, C.
1
M. A. Babu
1
M. Dara
1
M. M. Ahmmed
1
Machalaba
1
Machalaba, C.
1
Magalhães, C.R.
1
Malawi Human Rights Commission
1
MAMI, Irish Aid, Eleanor Crook Foundation
1
Martinez Viciana, C.
1
Mauder, S., K. Geffert
1
MEDBOX- The Aid libary
1
Medical Aid Films
1
Medicines and Healthcare products Regulatory Agency (MHRA) UK
1
Migration Policy Institute
1
Ministerio da Saude do Brasil
1
Ministerio de Salud Chile
1
Ministerio de Salud El Salvador
1
Ministerio de Salud Pública del Ecuador
1
Ministerio de Salud y Proteccion Social Bogota, Colombia
1
Ministerio de Salud, Colombia
1
Ministerio de Salud, Bogota, Colombia
1
Ministero della Salute
1
Ministère de la Santé, DR Congo
1
Ministério da Saúde Brasil
1
Ministério da Saúde, Brasil
1
Ministry of Health
1
Ministry of Health & Family Welfare ,India
1
Ministry of Health & Family Welfare Government of India
1
Ministry of Health & Family Welfare, Goverment of India
1
Ministry of Health and Family Welfare, India
1
Ministry of Health Ghana
1
Ministry of Health Rwanda, The DHS Program, et al.
1
Ministry of Health Uganda
1
Ministry of Health, Liberia, World Health Organization (WHO), and Centers for Disease Control and Prevention (CDC)
1
Ministry of Health, South Africa
1
Misereor, Brot für die Welt, Global Policy Forum GPF
1
Mixed Migration Centre
1
Morbidity and Mortality Weekly Report MMWR
1
Mortimer, K.
1
Msomi, N.
1
Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC)
1
N.Paul, T. Bärnighausen, P. Geldsetzer
1
National Academies of Sciences, Engineering, and Medicine
1
National Centre for Disease Control
1
National Department of Health (NDoH) South Africa
1
National Department of Health South Africa
1
National Department of Health South-Africa
1
National Libary of Medicine
1
NDoH South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
World Health Organization, Food and Agriculture Organization of the United Nations & World Organisation for Animal Health. (2021). Antimicrobial resistance and the United Nations sustainable development cooperation framework: guidance for United Nations country teams. World Health Organization
Organisation mondiale de la Santé, Organisation des Nations Unies pour l’alimentation et l’agriculture & Organisation mondiale de la santé animale. (2021). Résistance aux antimicrobiens et plan-cadre de coopération des Nations Unies pour le développement durable : orientations pour le...s équipes de pays des Nations Unies. Organisation mondiale de la Santé.more
The Strategic Tool for Assessing Risks (STAR) offers a comprehensive, easy-to-use toolkit and approach to enable national and subnational governments to rapidly conduct a strategic and evidence-based assessment of public health risks for planning and prioritization of health emergency preparedness a...nd disaster risk management activities. This guidance describes the principles and methodology of STAR to enhance its adaptation and use at the national or subnational levels.more
August 2021
This report presents the key findings of the NFHS-5 survey in Jharkhand, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India ...and each state and union territory.more
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in... the most recent guidance on HIV testing strategies - the entry point for HIV prevention and treatment - and include comprehensive guidance on infant diagnosis. Key recommendations are presented on rapid antiretroviral therapy (ART) initiation and the use of dolutegravir. Updated recommendations are included on the timing of ART for people with TB, and the use of point-of-care technologies for treatment monitoring.more
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...or. It aims to provide a set of evidence-based and pragmatic recommendations to drive comprehensive and integrated AMS activities under the purview of a central national coordination unit, National AMR steering or coordinating committees or other equivalent national authorities.
Available in English, French, Spanish, Russian, Arabic, Chinesemore
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...rmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.more
This report alerts responders to the importance of language in building trust and effective communication with people facing Ebola and other epidemics.
Ce rapport attire l’attention des intervenants sur le fait que la langue est importante pour établir la confiance avec les personnes touchées par le virus Ebola et d’autres épidémies et pour une communication efficace avec ces dernières.
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...table of all major issues in PLWH, recommendations on antiretroviral treatment, drug-drug interactions, diagnosis, monitoring and treatment of co-morbidities, co-infections and opportunistic diseases.
Available in English, French, Spanish, German, Portuguese, Russian, Chinese and Japanesemore
3rd edition. In 2001, Uganda adapted the Integrated Disease Surveillance and Response (IDSR) developed by World Health Organization (WHO) for member states in African region. The Ministry of Health has been implementing the IDSR strategy since then with success across the country. This strategy prov...ides the opportunity for rational use of resources and maximises investments in health surveillance systems. The 3rd edition IDSR guidelines incorporates lessons learnt from previous
epidemics, new frameworks like the Global Health Security Agenda (GHSA), One Health, Disaster Risk Management (DRM), the WHO regional strategy for health security and emergencies, and the rising non-communicable diseases, and aims to strengthen implementation of IHR (2005) core surveillance and response capacities. These guidelines have been adapted to reflect national priorities, policies and public health structures; and shall be used in conjunction with other similar
guidelines/strategies or initiatives.
Overall, the 3rd edition technical guidelines will incorporate the following:
• Strengthening Indicator Based Surveillance
• Strengthening Event Based Surveillance
• Improving community-based disease surveillance
• Improving Cross Border Surveillance and response
• Scaling up e-IDSR implementation
• Improving reporting and information sharing platforms
• Improved data sharing across sectors
• Tailoring IDSR to Emergency or Disaster contexts
The 3rd edition guidelines are intended for use as:
• A general reference for surveillance activities across all levels
• A set of definitions for thresholds that trigger some action for response
• A stand-alone reference for level-specific guidelines on surveillance and response
• A resource for developing training, supervision and evaluation of surveillance activities
• A guide for improving early detection and preparedness for outbreak response.more
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...s were shared through 70 presentations made by stake holders from all Regions. The presentations covered the key strategic approaches: global context, challenges in countries, contact tracing and post exposure prophylaxis, disability care, interruption of transmission and elimination of disease, stigma and d iscrimination, research. In addition to numerous comments received through the chat box and by email, the conclusions and recommendations of this Consultation will guide finalizing the post 2020 Global Leprosy Strategy.more
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the... decision has been made to specifically introduce and/or scale-up HPV virological testing for screening, which would be followed up with adequate management within the context of cervical cancer preventionmore